Fluticasone Propionate via the Diskhaler or Hydrofluoroalkane-134a Metered-Dose Inhaler on Methacholine-Induced Airway Hyperresponsiveness

This publication has 18 references indexed in Scilit:

• A Comparison of Fluticasone Propionate, 100??g Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma
  Clinical Drug Investigation, 2001
• Pharmaceutical transition to non-CFC pressurized metered dose inhalers
  Respiratory Medicine, 2000
• Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma
  Respiratory Medicine, 2000
• Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma
  Respiratory Medicine, 2000
• Effects of 2 weeks of treatment with fluticasone propionate 100 mcg b.d. by comparison with zafirlukast 20 mg b.d. on bronchial hyper-responsiveness in patients with mild to moderate asthma
  Respiratory Medicine, 2000
• Dose-Related Response to Inhaled Fluticasone Propionate in Patients with Methacholine-Induced Bronchial Hyperresponsiveness: A Double-Blind, Placebo-Controlled Study
  Journal of Asthma, 1998
• Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
  Thorax, 1995
• Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in Asthma
  American Review of Respiratory Disease, 1992
• The Shape of the Dose-Response Curve to Inhaled Bronchoconstrictor Agents in Asthma and in Chronic Obstructive Pulmonary Disease
  American Review of Respiratory Disease, 1991
• The origin of airway hyperresponsiveness
  Journal of Allergy and Clinical Immunology, 1986